Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bionostics in possible buyout talk:

This article was originally published in Clinica

Executive Summary

Bionostics, the medical diagnostics business formerly known as the Ferrari Group, last week (June 8) confirmed that it is in discussions with an unnamed party, which could lead to a possible takeover bid. The Birmingham, UK-based company saw its share price on the London AIM stock exchange rise by around 22% in the week after the announcement, rising from 23.5p to 28.25p ($46.40 to $55.78), and peaking at 31p. Bionostics provides a broad range of products and services in the liquid control and cryosystem sectors of the diagnostics industry.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048904

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel